BlackRock, Inc. 13D and 13G filings for Charles River Laboratories International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 3,524,401 6.900% | -714,096 (-16.85%) | Filing |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,238,497 8.200% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Sale | 2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,238,497 8.200% | -956,589 (-18.41%) | Filing |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,195,086 10.100% | -23,666 (-0.45%) | Filing |
| 2023-07-07 4:37 pm Purchase | 2023-06-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,218,752 10.200% | 237,607 (+4.77%) | Filing |
| 2023-01-24 1:56 pm Sale | 2022-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,981,145 9.800% | -98,881 (-1.95%) | Filing |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,080,026 10.100% | -289,587 (-5.39%) | Filing |
| 2021-01-26 6:52 pm Purchase | 2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,369,613 10.800% | 28,230 (+0.53%) | Filing |
| 2020-07-10 10:39 am Purchase | 2020-06-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,341,383 10.800% | 847,430 (+18.86%) | Filing |